245 related articles for article (PubMed ID: 23557870)
21. Hepatopulmonary syndrome.
Raevens S; Boret M; Fallon MB
JHEP Rep; 2022 Sep; 4(9):100527. PubMed ID: 36035361
[TBL] [Abstract][Full Text] [Related]
22. Impact of Liver Transplantation on Carbon Monoxide Production as Measured by Arterial Carboxyhemoglobin Levels in Cirrhotic Patients with and without Hepatopulmonary Syndrome.
Sabang RL; Abu-Hishmeh M; Bodin R; Epelbaum O
Ann Transplant; 2021 Sep; 26():e932009. PubMed ID: 34518507
[TBL] [Abstract][Full Text] [Related]
23. A case report of limitation of transcatheter hepatic arterial embolization for hereditary hemorrhagic telangiectasia type 2 with pulmonary arterial hypertension.
Nemoto N; Inami T; Onozawa S; Kohno T; Nagahama K; Soejima K; Hisamatsu T
Int J Surg Case Rep; 2024 Jun; 119():109634. PubMed ID: 38677256
[TBL] [Abstract][Full Text] [Related]
24. [Improve the understanding of hepatic disease related pulmonary vascular disease].
Xiong CM
Zhonghua Yi Xue Za Zhi; 2022 Oct; 102(38):2984-2987. PubMed ID: 36229197
[TBL] [Abstract][Full Text] [Related]
25. When common things aren't so common: A case report of hepatopulmonary syndrome.
Keelan E; Ferguson C; Kerr R
Clin Med (Lond); 2021 May; 21(3):226-227. PubMed ID: 34001574
[TBL] [Abstract][Full Text] [Related]
26. Liver Transplantation for Extra-Hepatic Manifestation of Hereditary Hemorrhagic Telangiectasia.
Park G; Stueck AE; Francheville J; MacNeil J; Zhu JH
Cureus; 2022 Aug; 14(8):e27968. PubMed ID: 36120248
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of liver transplantation in patients with hepatopulmonary syndrome in the pre and post-MELD eras: A systematic review.
Aragon Pinto C; Iyer VN; Albitar HAH; Anderson A; Cajigas H; Simonetto DA; Krowka MJ; DuBrock HM; Gallo de Moraes A
Respir Med Res; 2021 Nov; 80():100852. PubMed ID: 34418867
[TBL] [Abstract][Full Text] [Related]
28. Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis.
Kawut SM; Krowka MJ; Forde KA; Al-Naamani N; Krok KL; Patel M; Bartoli CR; Doyle M; Moutchia J; Lin G; Oh JK; Mottram CD; Scanlon PD; Fallon MB;
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 34949701
[TBL] [Abstract][Full Text] [Related]
29. The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.
Goldberg DS; Fallon MB
Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2118-27. PubMed ID: 25934564
[TBL] [Abstract][Full Text] [Related]
30. LTSI Consensus Guidelines: Preoperative Pulmonary Evaluation in Adult Liver Transplant Recipients.
Singh SA; Shrivastava P; Agarwal A; Nandakumar K; Nasa VK; Premkumar GV; Rajakumar A; Panchwagh A; Vohra V; Ranade S; Kumar L; Saraf N; Shah VR; Sudhidharan S
J Clin Exp Hepatol; 2023; 13(3):523-531. PubMed ID: 37250889
[TBL] [Abstract][Full Text] [Related]
31. Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2).
Al-Naamani N; Krowka MJ; Forde KA; Krok KL; Feng R; Heresi GA; Dweik RA; Bartolome S; Bull TM; Roberts KE; Austin ED; Hemnes AR; Patel MJ; Oh JK; Lin G; Doyle MF; Denver N; Andrew R; MacLean MR; Fallon MB; Kawut SM;
Hepatology; 2021 Feb; 73(2):726-737. PubMed ID: 32407592
[TBL] [Abstract][Full Text] [Related]
32. Resolution of Precapillary Pulmonary Hypertension After Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Systematic Review and Case Report.
Perrodin SF; Vogt AP; Berzigotti A; Kim-Fuchs C; Luedi MM; Candinas D; Banz VM
Transplant Proc; 2022; 54(1):135-143. PubMed ID: 34974893
[TBL] [Abstract][Full Text] [Related]
33. The impact of MELD exception points for hydrothorax on posttransplant mortality: a propensity score-matched analysis.
Fathma S; Boateng S; Amatya A; Ameyaw P; Banini BA
Eur J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38829948
[TBL] [Abstract][Full Text] [Related]
34. Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites.
Osman KT; Abdelfattah AM; Mahmood SK; Elkhabiry L; Gordon FD; Qamar AA
Dig Dis Sci; 2022 Oct; 67(10):4929-4938. PubMed ID: 35534742
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary function testing in patients with liver cirrhosis (Review).
Georgakopoulou VE; Asimakopoulou S; Cholongitas E
Med Int (Lond); 2023; 3(4):36. PubMed ID: 37533800
[TBL] [Abstract][Full Text] [Related]
36. Transportal Technetium-99m Labeled Macroaggregated Albumin Scintigraphy to Quantify Occult Intrahepatic Microvascular Portosystemic Shunting.
De la Garza-Ramos C; Muneer MS; Lewis JT; Harnois DM; Taner CB; Frey GT; Rosser B; Toskich BB
Radiol Case Rep; 2021 Apr; 16(4):975-978. PubMed ID: 33664925
[TBL] [Abstract][Full Text] [Related]
37. New therapeutic strategy with extracorporeal membrane oxygenation for refractory hepatopulmonary syndrome after liver transplant: A case report.
Sánchez Pérez B; Pérez Reyes M; Aranda Narvaez J; Santoyo Villalba J; Perez Daga JA; Sanchez-Gonzalez C; Santoyo-Santoyo J
World J Transplant; 2024 Mar; 14(1):89223. PubMed ID: 38576766
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary Dysfunction in Patients with Cirrhosis of the Liver: A Study of Pulmonary Function Tests and Arterial Blood Gases.
Vaishnav B; Barla DR; Ruchitha P; Wadivkar AN; Tonde T; Mondkar S
Int J Appl Basic Med Res; 2024; 14(1):48-53. PubMed ID: 38504842
[TBL] [Abstract][Full Text] [Related]
39. Hepatic hydrothorax is not associated with increased complications or poor survival after liver transplantation.
Osman KT; Cappuccio JM; Batarseh CI; Qamar AA
Expert Rev Gastroenterol Hepatol; 2023 Feb; 17(2):199-204. PubMed ID: 36620933
[TBL] [Abstract][Full Text] [Related]
40. Anesthetic Management Using Low Fraction of Inspiratory Oxygen for Living Donor Liver Transplantation in a Patient With Hepatopulmonary Syndrome Complicated by Interstitial Pneumonia: A Case Report.
Takahashi K; Imura K; Nobukuni K; Sasaki S; Nagano T; Harada N; Yoshizumi T; Higashi M; Yamaura K
Transplant Proc; 2021 Oct; 53(8):2556-2558. PubMed ID: 34465421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
